UBE2V1 and Alzheimer disease: In particular, GS1-304P7.3 showed increased expression in the AD group compared to the CTRL group, while NONHSAT090268, TC0100011037, TC0400008478, TC1400008125, and UBE2V1 levels were reduced in AD plasma samples compared to the CTRL group (Table 1).